The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
lipodystrophy and as you know that's the situation where there is no fat no sub-q fat or visceral fat these patients have no visceral fat huge livers hepatomegaly chock full of fat and liver and again diabetes through these mechanisms acetyl-coa driving gluconeogenesis and that's independent of visceral fat
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.